iRhythm Technologies Inc
iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring s… Read more
Market Cap & Net Worth: iRhythm Technologies Inc (IRTC)
iRhythm Technologies Inc (NASDAQ:IRTC) has a market capitalization of $3.80 Billion ($3.80 Billion) as of March 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #3432 globally and #2257 in its home market, demonstrating a -5.03% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying iRhythm Technologies Inc's stock price $117.53 by its total outstanding shares 32316760 (32.32 Million).
iRhythm Technologies Inc Market Cap History: 2016 to 2026
iRhythm Technologies Inc's market capitalization history from 2016 to 2026. Data shows growth from $969.50 Million to $3.80 Billion (17.36% CAGR).
Index Memberships
iRhythm Technologies Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.24 Trillion | 0.17% | #80 of 976 |
|
NASDAQ Composite
IXIC
|
$33.39 Trillion | 0.01% | #421 of 3165 |
Weight: iRhythm Technologies Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
iRhythm Technologies Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how iRhythm Technologies Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
7.68x
iRhythm Technologies Inc's market cap is 7.68 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $969.50 Million | $64.07 Million | -$20.90 Million | 15.13x | N/A |
| 2017 | $1.81 Billion | $99.13 Million | -$29.74 Million | 18.27x | N/A |
| 2018 | $2.25 Billion | $147.28 Million | -$50.38 Million | 15.25x | N/A |
| 2019 | $2.20 Billion | $214.55 Million | -$54.57 Million | 10.26x | N/A |
| 2020 | $7.67 Billion | $265.17 Million | -$43.83 Million | 28.91x | N/A |
| 2021 | $3.80 Billion | $322.82 Million | -$101.36 Million | 11.78x | N/A |
| 2022 | $3.03 Billion | $410.92 Million | -$116.16 Million | 7.37x | N/A |
| 2023 | $3.46 Billion | $492.68 Million | -$123.41 Million | 7.02x | N/A |
| 2024 | $2.91 Billion | $591.84 Million | -$113.29 Million | 4.92x | N/A |
| 2025 | $5.73 Billion | $747.14 Million | -$44.55 Million | 7.68x | N/A |
Competitor Companies of IRTC by Market Capitalization
Companies near iRhythm Technologies Inc in the global market cap rankings as of March 18, 2026.
Key companies related to iRhythm Technologies Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #78 globally with a market cap of $191.37 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #154 globally with a market cap of $121.03 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #168 globally with a market cap of $113.17 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #185 globally with a market cap of $105.26 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #78 | Abbott Laboratories | NYSE:ABT | $191.37 Billion | $110.71 |
| #154 | Stryker Corporation | NYSE:SYK | $121.03 Billion | $349.11 |
| #168 | Medtronic PLC | NYSE:MDT | $113.17 Billion | $88.44 |
| #185 | Boston Scientific Corp | NYSE:BSX | $105.26 Billion | $71.20 |
iRhythm Technologies Inc Historical Marketcap From 2016 to 2026
Between 2016 and today, iRhythm Technologies Inc's market cap moved from $969.50 Million to $ 3.80 Billion, with a yearly change of 17.36%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $3.80 Billion | -33.76% |
| 2025 | $5.73 Billion | +96.78% |
| 2024 | $2.91 Billion | -15.76% |
| 2023 | $3.46 Billion | +14.27% |
| 2022 | $3.03 Billion | -20.41% |
| 2021 | $3.80 Billion | -50.39% |
| 2020 | $7.67 Billion | +248.38% |
| 2019 | $2.20 Billion | -2.00% |
| 2018 | $2.25 Billion | +23.96% |
| 2017 | $1.81 Billion | +86.83% |
| 2016 | $969.50 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of iRhythm Technologies Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $3.80 Billion USD |
| MoneyControl | $3.80 Billion USD |
| MarketWatch | $3.80 Billion USD |
| marketcap.company | $3.80 Billion USD |
| Reuters | $3.80 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.